Speed
48 days to first decision for reviewed manuscripts only
33 days to first decision for all manuscripts
99 days from submission to acceptance
11 days from acceptance to publication

Epigenetics & Chromatin is a peer-reviewed, open access journal that publishes research, and reviews, providing novel insights into epigenetic inheritance and chromatin-based interactions. The journal aims to understand how gene and chromosomal elements are regulated and their activities maintained during processes such as cell division, differentiation and environmental alteration.

Research
Methodology
Review

Editors-in-Chief
Frank Grosveld, Erasmus University Medical Center, Netherlands 
Steven Henikoff, Fred Hutchinson Cancer Research Center, USA
Editorial Board
Julie Ahringer, The Gurdon Institute, University of Cambridge, UK 
Juan Ausió, University of Victoria, Canada 
Andrew Belmont, University of Illinois at Urbana-Champaign, USA 
Shelley Berger, The Wistar Institute, USA
Brad Bernstein, Massachusetts General Hospital, USA 
Timothy Bestor, Columbia University, USA 
Neil Brockdorff, Univeristy of Oxford, UK
Brad Cairns, University of Utah, USA 
Christoph Cremer, Institute of Molecular Biology, Germany 
Wouter de Laat, Erasmus University Medical Center, Netherlands 
Jerome Dejardin, Institute of Human Genetics, France 
Job Dekker, University of Massachusetts Medical School, USA 
Niall Dillon, Imperial College London, UK 
Gary Felsenfeld, National Institutes of Health, USA 
Anne Ferguson-Smith, University of Cambridge, UK 
Richard Festenstein, MRC, UK
Amanda Fisher, Imperial College London, UK
Peter Fraser, The Babraham Institute, UK 
Susan M Gasser, University of Geneva, Switzerland 
John Greally, Albert Einstein College of Medicine, USA
Shiv Grewal, National Institutes of Health, USA 
Joost Gribnau, Erasmus University Medical Center, Netherlands 
Gordon Hager, National Cancer Institute, USA 
Edith Heard, Curie Institute, France 
Steven Jacobsen, University of California, Los Angeles, USA 
Thomas Jenuwein, Max Planck Institute of Immunobiology and Epigenetics, Germany 
Peter Jones, University of Southern California, USA
Paul Kaufman, University of Massachusetts Medical School, USA
William Kelly, Emory University, USA 
Robert Kingston, Harvard Medical School, USA  
Andreas Ladurner, Ludwig-Maximilians-University Munich, Germany 
Jeannie Lee, Harvard Medical School, USA
Valerio Orlando, King Abdullah University of Science and Technology, Saudi Arabia 
Vincenzo Pirotta, Rutgers University, USA
Ana Pombo, Max Delbrueck Centre, Germany 
Oliver Rando, Harvard FAS Center for Systems Biology, USA 
Wolf Reik, The Babraham Institute, UK 
Gunter Reuter, Martin Luther University Halle-Wittenberg, Germany 
Jasper Rine, University of California, Berkeley, USA 
Eric Selker, Institute of Molecular Biology, USA 
Yang Shi, Harvard Medical School, USA
Ali Shilatifard, The Stowers Institute for Medical Research, USA 
M Mitchell Smith, University of Virginia Health System, USA 
David Spector, Cold Spring Harbor Laboratory, USA 
Francis Stewart, Dresden University of Technology, Germany 
Brian Strahl, University of North Carolina, USA 
Kevin Struhl, Harvard Medical School, USA 
Azim Surani, The Wellcome Trust & Cancer Research UK, UK 
Amos Tanay, Weizmann Institute of Science, Israel
David Tremethick, Australian National University, Australia 
Jessica Tyler, MD Anderson Cancer Center, USA
Maarten van Lohuizen, The Netherlands Cancer Institute, Netherlands 
Bas van Steensel, The Netherlands Cancer Institute, Netherlands 
Peter Verrijzer, Erasmus University Medical Centre, Netherlands 
Jörn Walter, Universität des Saarlandes, Germany 
Jerry Workman, Stowers Institute for Medical Research, USA
Anton Wutz, ETH Zurich, Switzerland 
Rui-ming Xu, Chinese Academy of Sciences,China
Phillip Zamore, University of Massachusetts Medical School, USA 
Yi Zhang, Harvard Medical School, USA